We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (2024-25)
Product name
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
Sponsor name
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Year Range
2024-25